Bayer Whistleblower Settlement Over Trasylol, Avelox and Baycol Results in $40 Million Payment
Bayer has agreed to pay $40 million to resolve a whistleblower lawsuit which accused it of kickback schemes and off-label marketing of the drugs Avelox, Baycol and Trasylol.